IQV - IQVIA Holdings Inc Stock Price, Fair Value and News

$144.00-4.44 (-2.99%)

Delayed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

IQV Price Action

Last 7 days

0.5%

Last 30 days

-23.6%

Last 90 days

-27.0%

Trailing 12 Months

-36.6%

IQV RSI Chart

IQV Valuation

Market Cap

25.4B

Price/Earnings (Trailing)

18.47

Price/Sales (Trailing)

1.65

EV/EBITDA

10.57

Price/Free Cashflow

9.34

IQV Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

IQV Fundamentals

IQV Revenue

Revenue (TTM)

15.4B

Rev. Growth (Yr)

2.33%

Rev. Growth (Qtr)

1.59%

IQV Earnings

Earnings (TTM)

1.4B

Earnings Growth (Yr)

-6.82%

Earnings Growth (Qtr)

53.33%

IQV Profitability

EBT Margin

10.83%

Return on Equity

22.63%

Return on Assets

5.1%

Free Cashflow Yield

10.71%

IQV Investor Care

Buy Backs (1Y)

2.98%

Diluted EPS (TTM)

7.49

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	15.1B	15.2B	15.3B	15.4B
2023	14.5B	14.7B	14.9B	15.0B
2022	14.0B	14.1B	14.3B	14.4B
2021	12.0B	12.9B	13.5B	13.9B
2020	11.2B	10.9B	11.0B	11.4B
2019	10.5B	10.7B	10.9B	11.1B
2018	9.9B	10.1B	10.2B	10.4B
2017	7.7B	8.5B	9.5B	9.7B
2016	5.9B	6.0B	6.1B	6.8B
2015	5.5B	5.6B	5.6B	5.7B
2014	5.2B	5.2B	5.4B	5.5B
2013	4.9B	5.0B	5.0B	5.1B
2012	4.5B	4.6B	4.7B	4.9B
2011	0	0	0	4.3B

Get all data in R, Python etc through our Historical Stock Data APIs

About IQVIA Holdings Inc

IQVIA Holdings Inc. engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and decentralized clinical trials, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was incorporated in 2016 and is headquartered in Durham, North Carolina.

CEO	Mr. Ari Bousbib
WEBSITE	iqvia.com
SECTOR	Healthcare
INDUSTRY	Diagnostics & Research
EMPLOYEES	65535

IQVIA Holdings Inc Frequently Asked Questions

What is the ticker symbol for IQVIA Holdings Inc? What does IQV stand for in stocks?

IQV is the stock ticker symbol of IQVIA Holdings Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of IQVIA Holdings Inc (IQV)?

As of Thu Apr 17 2025, market cap of IQVIA Holdings Inc is 25.36 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of IQV stock?

You can check IQV's fair value in chart for subscribers.

Is IQVIA Holdings Inc a good stock to buy?

The fair value guage provides a quick view whether IQV is over valued or under valued. Whether IQVIA Holdings Inc is cheap or expensive depends on the assumptions which impact IQVIA Holdings Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for IQV.

What is IQVIA Holdings Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu Apr 17 2025, IQV's PE ratio (Price to Earnings) is 18.47 and Price to Sales (PS) ratio is 1.65. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. IQV PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on IQVIA Holdings Inc's stock?

In the past 10 years, IQVIA Holdings Inc has provided 0.08 (multiply by 100 for percentage) rate of return.